Skip to main content
Top
Published in: International Journal of Clinical Oncology 6/2010

01-12-2010 | Case Report

A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome

Authors: Shuya Kandori, Koji Kawai, Yoshiharu Fukuhara, Akira Joraku, Naoto Miyanaga, Toru Shimazui, Hideyuki Akaza

Published in: International Journal of Clinical Oncology | Issue 6/2010

Login to get access

Abstract

A 40-year-old man was referred to our hospital for treatment of metastatic testicular cancer. Computerized tomography revealed multiple lung, liver, and retroperitoneal lymph node metastases. In addition, magnetic resonance imaging revealed multiple brain metastases. Induction chemotherapy with bleomycin, etoposide, and cisplatin was started the day after a high orchiectomy. The pathological diagnosis of the surgical specimen was yolk sac carcinoma. The serum human chorionic gonadotropin (hCG) was markedly increased to 630,000 mIU/ml, which suggested the presence of a choriocarcinoma element at metastatic sites. The patient subsequently suffered respiratory failure due to pulmonary hemorrhage. Intensive supportive care prevented a fatal outcome. Physicians who treat advanced testicular tumors should be aware of the potential complication of acute pulmonary hemorrhage, called choriocarcinoma syndrome, in cases with a high hCG level, which indicates a rapidly progressive and high-volume choriocarcinoma.
Literature
1.
go back to reference Williams SD, Birch R, Einhorn LH et al (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N Engl J Med 316:1435–1440PubMedCrossRef Williams SD, Birch R, Einhorn LH et al (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N Engl J Med 316:1435–1440PubMedCrossRef
2.
go back to reference Nichols CR, Catalano PJ, Crawford ED et al (1998) Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 16:1287–1293PubMed Nichols CR, Catalano PJ, Crawford ED et al (1998) Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 16:1287–1293PubMed
3.
go back to reference Miki T, Mizutani Y, Akaza H et al (2007) Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Int J Urol 14:54–59PubMedCrossRef Miki T, Mizutani Y, Akaza H et al (2007) Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Int J Urol 14:54–59PubMedCrossRef
4.
go back to reference Miki T, Mizutani Y, Nonomura N et al (2002) Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors. Cancer 95:1879–1885PubMedCrossRef Miki T, Mizutani Y, Nonomura N et al (2002) Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors. Cancer 95:1879–1885PubMedCrossRef
5.
go back to reference Logothetis CJ (1984) Choriocarcinoma syndrome. Cancer Bull 36:118–120 Logothetis CJ (1984) Choriocarcinoma syndrome. Cancer Bull 36:118–120
6.
go back to reference Logothetis CJ, Samuels ML, Selig DE et al (1986) Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med 81:219–227PubMedCrossRef Logothetis CJ, Samuels ML, Selig DE et al (1986) Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med 81:219–227PubMedCrossRef
7.
go back to reference Motzer RJ, Bosl GJ (1987) Hemorrhage: a complication of metastatic testicular choriocarcinoma. Urology 30:119–122PubMedCrossRef Motzer RJ, Bosl GJ (1987) Hemorrhage: a complication of metastatic testicular choriocarcinoma. Urology 30:119–122PubMedCrossRef
8.
go back to reference McKendrick JJ, Theaker J, Mead GM (1991) Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer 67:684–689PubMedCrossRef McKendrick JJ, Theaker J, Mead GM (1991) Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer 67:684–689PubMedCrossRef
9.
go back to reference Tatokoro M, Kawakami S, Sakura M et al (2008) Successful management of life-threatening choriocarcinoma syndrome with rupture of pulmonary metastatic foci causing hemorrhagic shock. Int J Urol 15:263–264PubMedCrossRef Tatokoro M, Kawakami S, Sakura M et al (2008) Successful management of life-threatening choriocarcinoma syndrome with rupture of pulmonary metastatic foci causing hemorrhagic shock. Int J Urol 15:263–264PubMedCrossRef
10.
go back to reference Kirch C, Blot F, Fizazi K et al (2003) Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors. Support Care Cancer 11:575–580PubMedCrossRef Kirch C, Blot F, Fizazi K et al (2003) Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors. Support Care Cancer 11:575–580PubMedCrossRef
Metadata
Title
A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome
Authors
Shuya Kandori
Koji Kawai
Yoshiharu Fukuhara
Akira Joraku
Naoto Miyanaga
Toru Shimazui
Hideyuki Akaza
Publication date
01-12-2010
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 6/2010
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0092-3

Other articles of this Issue 6/2010

International Journal of Clinical Oncology 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine